Company Filing History:
Years Active: 2008-2012
Title: Innovations in Immunotherapy by Charles Aylsworth
Introduction
Charles Aylsworth is an accomplished inventor based in Holt, Michigan. He has made significant contributions to the field of immunotherapy, particularly in the prevention and treatment of cancer and infectious diseases. With a total of two patents to his name, Aylsworth's work focuses on stimulating immune responses through innovative compositions and methods.
Latest Patents
Aylsworth's latest patents revolve around compositions and methods for immunotherapy targeting both primary and metastatic neoplastic diseases, as well as infectious diseases. His inventions provide alternative treatments to interleukin-12 (IL-12) by utilizing Apicomplexa-related proteins (ARPs) that exhibit immune stimulatory activity. These compositions are designed to elicit immune responses in subjects, offering new avenues for the prevention and treatment of various diseases.
Career Highlights
Throughout his career, Aylsworth has been associated with notable institutions such as Michigan State University and Barros Research Institute. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.
Collaborations
Aylsworth has collaborated with esteemed colleagues, including Siu-Cheong Ho and David Juckett. These partnerships have enriched his research endeavors and fostered innovation in the field of immunotherapy.
Conclusion
Charles Aylsworth's contributions to immunotherapy through his patents and collaborations highlight his dedication to advancing medical science. His innovative approaches offer promising solutions for combating cancer and infectious diseases.